Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("DOXORUBICINE N-TRIFLUOROACETYL VALERATE-14")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 33

  • Page / 2
Export

Selection :

  • and

QUANTITATIVE THIN-LAYER CHROMATOGRAPHIC MEASUREMENT OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD 32) AND TRIFLUOROACETYLADRIAMYCIN (AD 41) IN BLOOD AND TISSUESBARBIERI B; ABBRUZZI R; BENIGNI A et al.1979; J. CHROMATOGR.; NLD; DA. 1979; VOL. 163; NO 2; PP. 195-200; BIBL. 11 REF.Article

INITIAL CLINICAL EVALUATION OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD-32), AN ADRIAMYCIN ANALOGBLUM RH; GARNICK MB; ISRAEL M et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 919-923; BIBL. 20 REF.Article

DISTRIBUTION OF RADIOACTIVITY AND ANTHRACYCLINE-FLUORESCENCE IN TISSUES OF MICE ONE HOUR AFTER (14C)-LABELED AD32 ADMINISTRATION. EVIDENCE FOR TISSUE AGLYCONE FORMATIONISRAEL M; KARKOWSKY AM; KHETARPAL VK et al.1981; CANCER CHEMOTHER. PHARMACOL.; ISSN 0344-5704; DEU; DA. 1981; VOL. 6; NO 1; PP. 25-30; BIBL. 13 REF.Article

INHIBITION OF CHICKEN MYELOBLASTOSIS RNA POLYMERASE II ACTIVITY IN VITRO BY N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATECHUANG LF; KAWAHATA RT; CHUANG RY et al.1980; F.E.B.S. LETTERS; NLD; DA. 1980; VOL. 117; NO 1; PP. 247-251; BIBL. 16 REF.Article

THE IMMUNODEPRESSIVE AND HEMATOTOXIC ACTIVITIES OF N-TRIFLUORO-ACETYL-ADRIAMYCIN-14-VALERATEVECCHI A; SPREAFICO F; SIRONI M et al.1980; EUR. J. CANCER; ISSN 0014-2964; GBR; DA. 1980; VOL. 16; NO 10; PP. 1289-1296; BIBL. 27 REF.Article

EFFECT OF DAUNOMYCIN, ADRIAMYCIN AND ITS CONGENER AD 32 ON THE ACTIVITY OF DNASE I FROM BOVINE PANCREAS.FACCHINETTI T; MANTOVANI A; CANTONI R et al.1977; BIOCHEM. PHARMACOL.; G.B.; DA. 1977; VOL. 26; NO 20; PP. 1953-1954; BIBL. 21 REF.Article

POSSIBLE RELEVANCE OF N-TRIFLUOROACETYLADRIAMYCIN (AD 41) IN THE ANTITUMORAL ACTIVITY OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD 32) IN TUMOR-BEARING MICE. I: PHARMACOKINETIC EVIDENCEABBRUZZI R; RIZZARDINI M; BENIGNI A et al.1980; CANCER TREATM. REP.; USA; DA. 1980; VOL. 64; NO 8-9; PP. 873-878; BIBL. 16 REF.Article

ELECTRON MICROSCOPIC STUDIES OF THE HEART AND LIGHT MICROSCOPIC STUDIES OF THE SKIN AFTER TREATMENT OF GOLDEN HAMSTERS WITH ADRIAMYCIN, DETORUBICIN, AD-32 AND ACLACINOMYCINDANTCHEV D; SILIOUSSARTCHOUK V; PAINTRAND M et al.1979; CANCER TREATM. REP.; USA; DA. 1979; VOL. 63; NO 5; PP. 875-888; BIBL. 8 REF.Article

COMPARATIVE ANTINEOPLASTIC ACTIVITY OF ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE.VECCHI A; CAIRO M; MANTOVANI A et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 111-117; BIBL. 22 REF.Article

HEPATOBILIARY METABOLISM AND EXCRETION OF ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE IN THE RAT.ISRAEL M; WILKINSON PM; PEGG WJ et al.1978; CANCER RES.; U.S.A.; DA. 1978; VOL. 38; NO 2; PP. 365-370; BIBL. 24 REF.Article

URINARY ANTHRACYCLINE METABOLITES FROM MICE TREATED WITH ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE.ISRAEEL M; PEGG WJ; WILKINSON PM et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; U.S.A.; DA. 1978; VOL. 204; NO 3; PP. 696-701; BIBL. 18 REF.Article

Significance of the low-density lipoprotein (LDL) receptor pathway for the in vitro accumulation of AD-32 incorporated into LDL in normal and leukemic white blood cells = Importance de la voie du récepteur pour les lipoprotéines de faible densité (LDL) pour l'accumulation in vitro d'AD-32 incorporé dans LDL dans les leucocytes sanguins normaux et leucémiquesVITOLS, S; GAHRTON, G; PETERSON, C et al.Cancer treatment reports. 1984, Vol 63, Num 3, pp 515-520, issn 0361-5960Article

COMPARISON OF THE SENSITIVITIES OF HUMAN, CANINE, AND MURINE HEMATOPOIETIC PRECURSOR CELLS TO ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATEMARSH JC.1979; CANCER RES.; USA; DA. 1979; VOL. 39; NO 2; PP. 360-364; BIBL. 30 REF.Article

Radioactive species in rat urine and tissues after [14C] AD 32 administrationZINI, G; VICARIO, G. P; LAZZATI, M et al.Cancer chemotherapy and pharmacology. 1984, Vol 12, Num 3, pp 154-156, issn 0344-5704Article

DIFFERENCES IN CELLULAR UPTAKE AND CYTOFLUORESCENCE OF ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE. = DIFFERENCES D'INCORPORATION CELLULAIRE ET DE CYTOFLUORESCENCE DE L'ADRIAMYCINE ET DU VALERATE-14 DE N-TRIFLUOROACETYLADRIAMYCINEAWTAR KRISHAN; ISRAEL M; MODEST EJ et al.1976; CANCER RES.; U.S.A.; DA. 1976; VOL. 36; NO 6; PP. 2108-2110; BIBL. 13 REF.Article

INTERCALATION WITH DNA IS A PREREQUISITE FOR DAUNOMYCIN, ADRIAMYCIN AND ITS CONGENERS IN INHIBITING DNAASE I.FACCHINETTI T; MANTOVANI A; CANTONI L et al.1978; CHEMICO-BIOL. INTERACTIONS; NETHERL.; DA. 1978; VOL. 20; NO 1; PP. 97-102; BIBL. 10 REF.Article

N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE. ADDITIONAL MOUSE ANTITUMOR AND TOXICITY STUDIES.PARKER LM; HIRST M; ISRAEL M et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 119-127; BIBL. 20 REF.Article

A DIFFERENTIAL INTERACTION OF DAUNOMYCIN, ADRIAMYCIN, AND N-TRIFLUOROACETYLADRIAMYCIN 14-VALERATE WITH MOUSE PERITONEAL MACROPHAGESFACCHINETTI T; RAZ A; GOLDMAN R et al.1978; CANCER RES.; USA; DA. 1978; VOL. 38; NO 11; PP. 3944-3949; BIBL. 26 REF.Article

PROTEIN-ASSOCIATED DNA BREAKS AND DNA-PROTEIN CROSS-LINKS CAUSED BY DNA NONBINDING DERIVATIVES OF ADRIAMYCIN IN L1210 CELLSLEVIN M; SILBER R; ISRAEL M et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 3; PP. 1006-1010; BIBL. 36 REF.Article

IN VIVO EFFECTS OF ADRIAMYCIN OR N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE ON A MOUSE LYMPHOMA = EFFETS DE L'ADRIAMYCINE ET DU N-TRIFLUOROACETYLADRIAMYCINE-14-VALERATE SUR UN LYMPHOME DE SOURIS IN VIVOPOTMESIL M; LEVIN M; TRAGANOS F et al.1983; EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY; ISSN 0277-5379; GBR; DA. 1983; VOL. 19; NO 1; PP. 109-122; ABS. ENG; BIBL. 50 REF.; GRAPHArticle

PHARMACOLOGIC STUDIES WITH RADIOLABELED N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE (AD32): COMPARISON OF TOTAL ANTHRACYCLINE FLUORESCENCE AND RADIOACTIVITY IN MOUSE SERUM AND URINEISRAEL M; KARKOWSKY AM; PEGG WJ et al.1980; CANCER CHEMOTHER. PHARMACOL.; DEU; DA. 1980; VOL. 4; NO 2; PP. 79-82; BIBL. 21 REF.Article

ETUDE ULTRASTRUCTURALE DE LA CARDIOTOXICITE ET DES ALTERATIONS DE LA PEAU CHEZ LE HAMSTER DORE APRES TRAITEMENT AVEC HUIT DIFFERENTES ANTHRACYCLINESDANTCHEV D; SLIOUSSARTCHOUK V; PAINTRAND M et al.1979; C.R. SOC. BIOL.; FRA; DA. 1979; VOL. 173; NO 2; PP. 394-413; BIBL. 12 REF.Article

ANTITUMOR ACTIVITY OF N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE.PRATESI G; CASAZZA AM; DI MARCO A et al.1978; CANCER TREATM. REP.; U.S.A.; DA. 1978; VOL. 62; NO 1; PP. 105-110; BIBL. 13 REF.Article

COMPARATIVE EFFECTS OF ADRIAMYCIN AND N-TRIFLUOROACETYLADRIAMYCIN-14-VALERATE ON CELL KINETICS, CHROMOSOMAL DAMAGE, AND MACROMOLECULAR SYNTHESIS IN VITROKRISHAN A; DUTT K; ISRAEL M et al.1981; CANCER RES.; ISSN 0008-5472; USA; DA. 1981; VOL. 41; NO 7; PP. 2745-2750; BIBL. 29 REF.Article

ULTRASTRUCTURAL STUDY OF THE CARDIOTOXICITY AND LIGHT-MICROSCOPIC FINDINGS OF THE SKIN AFTER TREATMENT OF GOLDEN HAMSTERS WITH SEVEN DIFFERENT ANTHRACYCLINESDANTCHEV D; SLIOUSSARTCHOUK V; PAINTRAND M et al.1980; RECENT RESULTS CANCER RES.; ISSN 0080-0015; USA; DA. 1980; NO 74; PP. 223-249; BIBL. 12 REF.Article

  • Page / 2